Skip to NavigationSkip to content

Pharmafile - Research and Development News

To find out more, check out this week’s Top 10 most popular articles on Pharmafile.com now!
Novartis has revealed data from a range of multinational, real-world studies which reinforced the efficacy of its interleukin-17A inhibitor Cosentyx...
Celgene has revealed that Otezla (apremilast) achieved “meaningful improvements” in outcomes of patients with moderate to severe plaque psoriasis...
Janssen has unveiled new Phase 3 data derived from two separate trials on the efficacy and benefits of switching to its Interleukin-23 (IL-23)-...
Japanese multinational Takeda is set to shut down its US headquarters in Deerfield, Illinois following the final stages of its Shire Plc acquisition...
Bavencio combined with Inlyta has shown strong results in a Phase 3 trial investigating its efficacy as a first-line therapy for patients with...
Bristol-Myers Squibb has unveiled new Phase 2 data for its investigational oral, selective tyrosine kinase 2 (TYK2) inhibitor, known as BMS-986165...
Public Health England has revealed that an enhanced, “adjuvanted” vaccine is to be made available for over-65s this winter, and could save hundreds...
British Health Secretary Matt Hancock has said that pharmaceutical companies are trying to “rip off taxpayers” and that big business should act in a...
Protesters in Manchester have called on the National Institute of Health and Care Excellence (NICE), to overturn their rejection of the Spinal...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches